Technavio expects global diabetic eye disease devices market worth $686.5 million by 2020

Renewable energy

 

This market research report presents a detailed segmentation of the global diabetic eye disease devices market by product type (vitrectomy packs, retinal lasers, vitrectomy machines, and others), by technology (laser surgery and vitrectomy), and by geography (Americas, APAC, and EMEA). The key leading vendors in the market are Alcon, Ellex, IRIDEX, Synergetics USA, and Topcon.

Technavio has released a new market research report on the global diabetic eye disease devices market, which is expected to grow at a CAGR of 8% between 2016 and 2020. Increase in the incidences of diabetic eye disorders including diabetic retinopathy, macular degeneration, cataracts, and glaucoma are driving the demand for diabetic eye disease devices. The Americas dominate the global market for diabetic eye disease devices, and accounts for 55% of eth total market share. Owing to rising incidence of diabetes in the region among older people, the demand for thses devices is more.

The new industry research report from Technavio discusses in detail the key drivers and trends responsible for the growth of this market and its sub-segments.

“The market is witnessing advances in laser technology which has led to the introduction of many new laser types such as pattern scan laser, low-fluence laser, short-pulse duration, and navigated laser systems for macular edema and proliferative diabetic retinopathy. These technological advancements have brought about a revolution in the ophthalmic industry in the last decade. For instance, pattern scans laser technology offers quick and comfortable treatment for diabetic retinopathy, thereby propelling the growth prospects of this market over the forecast period,” says Barath Palada, Lead Analyst, Healthcare & Lifesciences, Technavio Research

Currently, the vitrectomy segment dominates the market, occupying nearly 63% of the overall market share. Vitrectomy is a microsurgical procedure used to address advanced stages of diabetic eye diseases. The process involves the removal of the blood-filled vitreous, and its replacement with a clear solution. The chances of losing vision and blindness are high if the surgical reattachment of the retina is performed incorrectly.

The key vendors in the global diabetic eye disease devices market include Alcon, Ellex, IRIDEX, Synergetics USA, and Topcon. This market is highly competitive and characterized by the technological advancements and innovation. The market has several small and regional vendors developing strategic alliances with global players to gain market share.  Factors like increased product portfolio extensions, advances in technology, and R&D have resulted in intense competition among vendors. The competition is expected to intensify with vendors using innovative marketing strategies to gain market presence.

A more detailed analysis is available in the Technavio report, Global Diabetic Eye Disease Devices Market 2016-2020.

We can customize reports by other regions and specific segments upon request.

Other related reports:

·  Global Ophthalmic Therapeutic Market 2015-2019

·  Global Choroidal Neovascularization Market 2016-2020

·  Global Diabetic Retinopathy Market 2015-2019

·  Global Retinoblastoma Treatment Market 2015-2019